A Study Based on Medical Records That Looks at the Duration of Use of Two Types of Inhalers With Different Medicines in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT03979807 · clinicaltrials.gov ↗

COMPLETED

Status

11296

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Olodaterol/Tiotropium Bromide
DRUG: Umeclidinium/ Vilanterol

Sponsor

Boehringer Ingelheim